Zykadia (Ceritinib) Capsules
Trade name : Zykadia.
Zykadia is manufactured by Novartis Pharms Corp.
Zykadia FDA Approval :
Zykadia first approved April 29, 2014.
Zykadia Dosage form :
Capsules: 150 mg.
Zykadia Indications and Usage :
Non-Small Cell Lung Cancer
Indicated for anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to crizotinib.
Zykadia (Ceritinib) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.